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Abstract
Purpose
There is a strong association between severe hyperhomocysteinemia and myopia. Thus we
studied the hypothesis that even moderately increased levels of homocysteine (Hcy) might
be a potentially treatable risk factor for myopia.
Methods
The Gutenberg Health Study (GHS) is a population-based, prospective, observational
cohort study in Germany, including 15,010 participants aged between 35 and 74 at recruit-
ment. The baseline examination was conducted from 2007–2012. Refraction was measured
using autorefraction (HARK 599, Carl Zeiss AG, Jena, Germany). Hcy was measured by an
immunoassay. We included only phakic participants without a history of corneal surgery or
corneal laser treatment. We used linear regression models to evaluate the potential associa-
tion between Hcy and refraction at baseline, and between Hcy and change in refraction
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between baseline and 5-year-follow-up examination. We used generalized estimating equa-
tion models to account for the correlation between fellow eyes.
Results
We included 13,749 participants, categorized as having no myopia (spherical equivalent >
-0.75 D, 65.2%), low myopia (-0.75 D–-2.75 D, 21.5%), moderate myopia (-3.00 D– 5.75 D,
9.8%) and high myopia (� -6 D, 3.5%). Median Hcy levels were similar in all groups (μmol/l).
We observed no association of Hcy with refraction or 5-year change in refraction in the mod-
els adjusted for age, sex and socioeconomic status.
Conclusion
We found no evidence for an association of Hcy levels and refractive error.
Introduction
Myopia is a worldwide increasing health challenge not only requiring optical aids such as
glasses or contact lenses but also increasing the risk of severe secondary eye diseases such as
glaucoma, cataract and macular degeneration [1]. Both hereditary and environmental risk fac-
tors have been identified or suspected [2]. In this exploratory study, we aim to evaluate
whether elevated levels of homocysteine (Hcy) might be an additional risk factor for the devel-
opment of myopia. The normal level of plasma Hcy is 5–15 μmol/l, and therapy is usually initi-
ated if plasma Hcy is above 50μmol/l [3]. Patients with classical hyperhomocysteinemia
typically present with myopia and if untreated even with ectopia lentis. Other symptoms that
may occur are mental retardation, marfanoid habitus, osteoporosis, thromboembolic events
and behavioral deficits [4]. Milder forms exist and may manifest late in adulthood with myopia
or ectopia lentis as a first sign while others may even remain asymptomatic for many years [5,
6]. In a cohort of patients with late-diagnosed hyperhomocysteinemia, all 14 had lens subluxa-
tion or dislocation at diagnosis [7]. Some of them attended ophthalmologic care for many
years before diagnosed with hyperhomocysteinemia because of lens subluxation and progres-
sive myopia. All patients with poor biochemical control were myopic. Given the very strong
association between severe hyperhomocysteinemia and myopia, we hypothesized that even
moderately increased levels of Hcy might be a risk factor for myopia [3, 8]. We assume that
moderately increased Hcy would be present over the entire life span and could thus be
detected in our adult study sample.
Materials and methods
Study population
The Gutenberg Health Study (GHS) is an ongoing population-based, prospective, single-cen-
ter cohort study at the medical center of the Johannes Gutenberg University Mainz in Ger-
many [9]. The sample was randomly drawn and equally stratified by sex and area of residence
for each decade of age. Exclusion criteria were insufficient knowledge of German and physical
or mental inability to participate in the examinations in the study center. The study protocol
and study documents were approved by the local ethics committee of the Medical Chamber of
Rhineland-Palatinate, Germany. According to the tenets of the Declaration of Helsinki, writ-
ten informed consent was obtained from all participants prior to entering the study. The
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baseline examination with a total of 15,010 participants aged 35 to 74 years took place from
2007 to 2012 and comprised an ophthalmic examination, several general and cardiovascular
examinations, as well as interviews, and questionnaires [10]. The five-year-follow-up started in
April 2012 and was finished in April 2017. For the analysis of refraction, we included all partic-
ipants with available information on Hcy and refraction at baseline and with phakic lens status
and no history of corneal surgery or corneal laser treatment. For the analysis of 5-year change
in refraction, we further excluded all participants without Hcy or refraction measurements at
the 5-year follow-up examination and with lens replacement surgery, corneal surgery or cor-
neal laser treatment between baseline and follow-up examination.
Homocysteine measurements
Peripheral venous blood samples were obtained according to standard operation procedures,
using a sampling container with a Hcy-stabilizing additive (“S-Monovette1HCY-Z-Gel”, Sar-
stedt AG & Co, Nu¨rnberg, Germany), and were subsequently transported on ice to the main
laboratory. After cooled centrifugation homocysteine was measured in plasma by immunoassay
on an Architect i2000SR analyzer (Abbott Diagnostics, Wiesbaden, Germany). We categorized
Hcy levels into normal (< = 15 μmol/l), mild hyperhomocysteinemia (>15 to< = 30 μmol/l),
intermediate hyperhomocysteinemia (> 30 to< = 100 μmol/l), and serious hyperhomocystei-
nemia (> 100 μmol/l) [11].
Ophthalmologic parameters
The ocular characteristics were obtained during the ophthalmological examination as
described elsewhere [10]. In brief, non-cycloplegic refraction and best-corrected distance
visual acuity were measured in both eyes, starting with the right eye, using a Humphrey Auto-
mated Refractor / Keratometer (HARK) 599 (Carl Zeiss AG, Jena, Germany). Visual acuity
was measured using the built-in Snellen charts, ranging from 20/400 to 40/20 (decimal 0.05 to
2.0). For lower levels of visual acuity, we used a visual acuity chart at a distance of one meter
up to 20/800, and then counting fingers, hand movements, and test of light perception. The
spherical equivalent (SE) was calculated as the spherical correction value plus half the cylindri-
cal power. Participants were then categorized by their SE into having low myopia (< = -0.5 D
—>-6 D in either eye), high myopia (< = -6D in either eye), or no myopia (>-0.5 D in both
eyes), following the recent International Myopia Institute (IMI) recommendation [12]. Intra-
ocular pressure (IOP) was measured with an air-puff noncontact tonometer (Nidek NT-2000;
Nidek, Co., Gamagori, Japan). Starting with the right eye, the mean of three measurements
within a 3-mmHg range was obtained for each eye. Information on lens status and previous
eye surgery was obtained from the medical history collected preceding the ophthalmological
examination. Self-reported lens status at baseline was validated by slit-lamp examination [13].
Socio-demographic characteristics and comorbidities
During a computer-assisted personal interview participants were asked about their medical
history and income, school education, vocational training, and occupational status. The socio-
economic status (SES) was defined based on income, education and position according to the
SES-index used within the German Health Update 2009 (GEDA), with a range from 3 to 21 (3
indicates the lowest SES and 21 the highest SES) [14]. Diabetes mellitus was defined by fulfill-
ing one of the following criteria: diabetes mellitus diagnosed by a physician, known therapy
(oral medication or insulin), or HbA1c > = 6.5%. Dyslipidemia was defined by a low-density
lipoprotein (LDL) to high-density lipoprotein ratio (LDL/HDL) of>3.5, lipid-lowering medi-
cation, or diagnosis by a physician. Hypertension was defined by the use of antihypertensive
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medication, mean systolic blood pressure� 140 mm Hg or mean diastolic blood
pressure� 90 mm Hg in 3 consecutive measurements at rest, or diagnosis of arterial hyperten-
sion by physician. Smoking was dichotomized into current smokers and non-smokers (includ-
ing past smokers). Obesity was defined as a BMI > = 30 m2/kg.
Statistical analysis
For continuous variables, we calculated median and 25th and 75th percentiles, and mean and
standard deviation for approximately normal distributed variables. We used linear regression
models with general estimating equations for consideration of the correlation between fellow
eyes to assess the association of Hcy and refraction and change in refraction [15]. Model 1
included no covariates; model 2 was adjusted age, sex and socio-economic status. For the iden-
tification of potential confounders we followed the directed acyclic graph (DAG) concept [16].
We used the online tool DAGitty V2.3 (http://dagitty.net/, last accessed 2019-08-16) to visual-
ize potential causal relationships (S1 Fig) and to derive the minimal sufficient adjustment set
for estimating the total effect of Hcy on refraction [17]. As sensitivity analyses, we additionally
calculated the regression models split my sex, limited to participants with Hcy>15 μmol/l,
and limited to participants without severe astigmatism (Cyl > -1 diopter in both eyes). Due to
the exploratory character of this study, we did not adjust for multiple testing. P-values should
be interpreted with caution and in connection with effect estimates. We used R version 3.5.2
(2018-12-20) for the analysis [18].
Results
After exclusion of 386 participants without refraction, 114 without homocysteine measure-
ments, 677 with pseudophakia, and 84 with previous refractive surgery, our analysis of Hcy and
refraction was based on 13,749 subjects (Table 1). 63% (n = 8,609) had no myopia, 33%
(n = 4,540) had low myopia, and 4% (n = 600) had high myopia. 86% (n = 11,814) had normal
Hcy levels (< = 15 μmol/l), 13% (n = 1840) mild hyperhomocysteinemia (>15 to< = 30 μmol/
l), 0.7% (n = 91) intermediate hyperhomocysteinemia (> 30 to< = 100 μmol/l), and n = 4 seri-
ous hyperhomocysteinemia (> 100 μmol/l).
Homocysteine levels were lower in women (median 10.1 μmol/l, 25th and 75th percentiles
8.50, 12.07) than in men (median 12.0 μmol/l, 10.30, 14.30).
The mean spherical equivalent was similar across categories of Hcy levels, and we did not
observe a relation of Hcy levels and refraction (Figs 1 and 2), and the distribution of low and
high myopia was similar as well (S2 Fig). In Hcy levels higher than 100 μmol/l, there are only
few observations (n = 4). In the univariate linear regression analysis, a 10 μmol/l higher Hcy
level was associated with a 0.17 D more myopic refraction (95% confidence interval 0.10–0.23).
After adjusting for age, sex and socio-economic status, this association was no longer present
(Table 2).
Our analysis of 5-year change in refraction was based on 9,928 participants (S1 Table). The
mean change in refraction was 0.09 diopters (standard deviation 0.63). Again, we found no
evidence for an association with Hcy, neither in the plots (S3 and S4 Figs), nor in the univariate
and the adjusted regression analysis (Table 3).
The analyses stratified for men and women, as well as restricted to participants with homo-
cysteinemia >15 μmol/l, and restricted to participants without severe astigmatism (both eyes
cylinder > -1 diopter) revealed also no association (S3 Table).
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Discussion
We found no evidence for an association between Hcy and refraction or 5 year-change in
refraction. To our knowledge, this is the first study that has evaluated a potential relationship
of Hcy and myopia. We assumed that moderately increased Hcy would be present over the
Table 1. Characteristics of the baseline sample of the German population-based Gutenberg Health Study (GHS), 2007–2012.
Overall (n = 13,749) Men (n = 6975, 50.7%) Women (6774, 49.3%)
Age [years] 54.42 (10.93) 54.71 (10.95) 54.12 (10.89)
Socio-economic status 13.00 [9.00, 17.00] 13.50 [10.00, 18.00] 12.00 [9.00, 15.00]
Hypertension 6701 (48.8) 3749 (53.8) 2952 (43.6)
Diabetes mellitus 1203 (8.7) 750 (10.8) 453 (6.7)
Dyslipidemia 4693 (34.2) 2986 (42.9) 1707 (25.2)
Obesity (BMI> = 30) 3404 (24.8) 1802 (25.8) 1602 (23.7)
Smoking 2717 (19.8) 1480 (21.3) 1237 (18.3)
Self-reported cancer 1184 (8.6) 535 (7.7) 649 (9.6)
Sphere (OD) [diopter] -0.12 (2.50) -0.13 (2.41) -0.11 (2.59)
Sphere (OS) [diopter] -0.12 (2.49) -0.13 (2.43) -0.10 (2.55)
Cylinder (OD) [diopter] -0.57 (0.66) -0.59 (0.68) -0.54 (0.64)
Cylinder (OS) [diopter] -0.56 (0.65) -0.58 (0.66) -0.54 (0.63)
Spherical equivalent (OD) [diopter] -0.41 (2.53) -0.43 (2.44) -0.38 (2.63)
Spherical equivalent (OS) [diopter] -0.39 (2.52) -0.42 (2.45) -0.36 (2.59)
Visual acuity (OD) [logMAR] 0.00 [0.00, 0.10] 0.00 [0.00, 0.10] 0.00 [0.00, 0.10]
Visual acuity (OS) [logMAR] 0.00 [0.00, 0.10] 0.00 [0.00, 0.10] 0.00 [0.00, 0.10]
Homocysteine [μmol/l] 11.10 [9.30, 13.30] 12.00 [10.30, 14.30] 10.10 [8.50, 12.07]
For categorical variables: absolute (relative) frequencies; for continuous variables: mean (standard deviation), in case of skewed distribution median (25th/ 75th
percentile).
https://doi.org/10.1371/journal.pone.0231011.t001
Fig 1. The distribution of refraction in relation to homocysteine levels in the baseline sample of the German
population-based Gutenberg Health Study (GHS), 2007–2012. Smoothing line with 95% confidence bands based on
locally weighted scatterplot smoothing (LOESS).
https://doi.org/10.1371/journal.pone.0231011.g001
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entire life span and could thus be detected in our adult study sample. Given the proposed
pathophysiological mechanism underlying the association of severe hyperhomocysteinemia
and progressive myopia, namely that the extremely high Hcy concentration disrupts the zonu-
lar fibers, long-term exposure to moderately increased Hcy might also result in ocular effects
like a more myopic refraction compared to the general population, and/or a continuous
change towards more myopic refraction. This effect might either be observable cross-section-
ally or in change over time–but we did not observe any effect in our study sample.
A limitation of our study is a lack in precision in the measurement of refraction by using
autorefraction without cycloplegia. There is evidence from epidemiologic studies that the
resulting misclassification is higher in children but not limited to this age group [19]. Further-
more, the misclassification is dependent on refractive error—our study outcome [20]. There-
fore, there is the risk of a bias that might have diluted the effect we tried to explore. Despite
this limitation, previous analyses e.g. on the relationship between refraction and education
revealed that our measurement method is sufficiently precise to detect associations [21], but
this does not necessarily be the case for the subject of current analysis. Another potential limi-
tation could be the exclusion of 761 participants with a history of ocular surgery. By doing so,
we might have excluded those participants with ectopia lentis due to high Hcy. On the other
hand, our aim was to evaluate a potential influence of Hcy elevations below the threshold com-
monly used to initiate therapy, and these estimates would be unbiased by excluding severe
Fig 2. Refraction in relation to grouped baseline homocysteine levels in the German population-based Gutenberg
Health Study (GHS) 2007–2012. Outliers more extreme than 11 diopters are not displayed. N included in
homocysteine categories (left to right): 36, 4836, 6942, 1484, 272, 84, 91, 4.
https://doi.org/10.1371/journal.pone.0231011.g002
Table 2. Association of homocysteine levels with diopters of spherical equivalent–Results from the German population-based Gutenberg Health Study (GHS).
Univariate (27,348 eyes) Adjusted for age, sex, and socio-economic status (27,348
eyes)
Estimate (CI) p-value Estimate (CI) p-value
Homocysteine [10 μmol/l] 0.17 (0.10–0.23) 6.58E-07 -0.04 (-0.11–0.02) 0.15
Results from linear regression, using generalized estimating equation models to account for the correlation of fellow eyes, p value derived by Wald score test.
https://doi.org/10.1371/journal.pone.0231011.t002
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cases of hyperhomocysteinemia. Hcy levels below this threshold are unlikely to influence the
likelihood of participants to take part in the GHS, because there would be no effect on health
and everyday life. Therefore we expect no selection bias. Hcy levels of participants might be
influenced by the supplementary intake of vitamins. We were not able to account for vitamin
status, intake of supplementary vitamins, and a history of hyperhomocysteinemia treatment in
our analysis, because the data has not been collected. On the other hand, strengths of our study
are the standardized sampling and examination program of the GHS ensuring a high data
quality, and the large, population-based sample.
In summary, this is the first study to report on the potential association of Hcy levels and
refraction in a large population-based sample. We found no evidence for an association of Hcy
and refraction.
Supporting information
S1 Fig. Directed acyclic graph (DAG) to visualize causal relationships and to derive the
minimal sufficient adjustment set for estimating the total effect of plasma homocysteine
on refraction. Generated with DAGitty 2.3 (http://dagitty.net/, last accessed 2019-08-19).
SES = socio-economic status
(TIF)
S2 Fig. Distribution of myopia categories by groups of homocysteine levels in the German
population-based Gutenberg Health Study (GHS), 2007–2012. Low myopia: spherical
equivalent < = -0.5 D—>-6 D in either eye; high myopia: spherical equivalent < = -6 D in
either eye, no myopia: spherical equivalent > -0.5 D in both eyes. N included in homocysteine
categories (left to right): 36, 4836, 6942, 1484, 272, 84, 91, 4.
(TIF)
S3 Fig. Change in refraction (comparing 5-year-follow-up with baseline) in relation to
baseline homocysteine levels in the German population-based Gutenberg Health Study
(GHS). Smoothing line with 95% confidence bands based on locally weighted scatterplot
smoothing (LOESS).
(TIF)
S4 Fig. Change in refraction (comparing 5-year-follow-up with baseline) in relation to
grouped baseline homocysteine levels in the German population-based Gutenberg Health
Study (GHS). N included in homocysteine categories (left to right): 36, 4836, 6942, 1484, 272,
84, 91, 4.
(TIF)
S1 Table. Baseline characteristics of the German population-based Gutenberg Health
Study (GHS) subsample for the analysis of 5-year change in refraction in relation to base-
line homocysteine levels.
(PDF)
Table 3. Association of homocysteine levels with 5-year-change in diopters of spherical equivalent–Results from the German population-based Gutenberg Health
Study (GHS).
Univariate (19,768 eyes) Adjusted for age, sex, and socio-economic status (19,768
eyes)
Estimate (CI) p-value Estimate (CI) p-value
Homocysteine [10 μmol/l] -0.01 (-0.03–0.02) 0.52 -0.02 (-0.05–0.00) 0.07
Results from linear regression, using generalized estimating equation models to account for the correlation of fellow eyes, p value derived by Wald score test.
https://doi.org/10.1371/journal.pone.0231011.t003
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S2 Table. Distribution homocysteine levels by myopia categories in the baseline sample of
the German population-based Gutenberg Health Study (GHS), 2007–2012.
(PDF)
S3 Table. Association of homocysteine levels (per 10 μmol/l]) with diopters of spherical
equivalent (sensitivity analyses)–results from the German population-based Gutenberg
Health Study (GHS).
(PDF)
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